课题基金 / 基金详情

Search for effective constituents for life-style related diseases through expression of PPAR

Search for effective constituents for life-style related diseases through expression of PPAR
通过PPAR表达寻找生活方式相关疾病的有效成分
批准号:
22510240
负责人:
MATSUDA Hisashi
金额:
$2.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

MATSUDA Hisashi的其他基金

相似基金

相关文献

中文摘要
翻译
我们主要关注阿育吠陀传统医学,通过过氧化物酶体增殖激活受体(PPAR)的表达,研究了治疗生活方式相关疾病的有效成分。结果发现,产自印度和东南亚的山柰(Kaempferia parviflora)、莲花(Nelumbo nucifera)的therhi茎提取物和成分,以及沙巴胡椒(Piper chaba)果实的酰胺成分对3T3-L1脂肪细胞具有类似PPARγ激动剂的作用。活性成分3,5,7,3 ',4 ' -五-甲氧基黄酮醇,n -去甲花籽碱,胡椒明及其衍生物均能增强PPARγ2, C/EBPα和β mRNA,但对PPARγ水平的拮抗作用较弱。此外,在给药哌隆明和逆转录酶甲酰胺A后测定小鼠血浆浓度,并合成逆转录酶甲酰胺A及其衍生物,以寻找更有效的成分。
英文摘要
We mainly focused on Ayurvedic traditional medicine and have researched the active constituents for therapeutics of life-style related diseases through expression of peroxisome proliferator-activated receptor (PPAR). As the results, the extracts and the constituents from therhizomes of Kaempferia parviflora, flower of Nelumbo nucifera, and amide constituents from the fruit of Piper chaba, which are cultivated in India as well as southeast Asia, were found to show PPARγ agonist-like effects in 3T3-L1 adipocytes. The active constituents, 3,5,7,3’,4’-penta- mehoxyflavonol, N-nornuciferine, piperlonguminine, and their derivatives showed enhancement of PPARγ2, C/EBPα and β mRNA, although they had less agonistic activity at PPARγ levels. Furhermore,plasma concentrations were determined after administration of piperlonguminine and retrofractamide A in mice, together with synthesis of retrofactamide A and its derivatives to find more effectiveconstituents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
フラボノイド類の脂肪細胞分化誘導活性.
类黄酮的脂肪细胞分化诱导活性。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Shimo T, Matsukubo H, Zhang H-M, 松田久司,小神雄一郎,杉山智美,上野翼,中村誠宏,吉川雅之]
通讯作者: 松田久司,小神雄一郎,杉山智美,上野翼,中村誠宏,吉川雅之
DOI: 10.1007/s11418-013-0770-3
发表时间: 2013-04
期刊: Journal of Natural Medicines
影响因子: 3.3
作者: [Itadaki Yamaguchi;H. Matsuda;Hailong Zhang;M. Hamao;Chihiro Yamashita;Yuichiro Kogami;Haruka Kon'i;Megumi Murata;Seikou Nakamura;M. Yoshikawa]
通讯作者: Itadaki Yamaguchi;H. Matsuda;Hailong Zhang;M. Hamao;Chihiro Yamashita;Yuichiro Kogami;Haruka Kon'i;Megumi Murata;Seikou Nakamura;M. Yoshikawa
Osamu Muraoka, Takao Hayakawa, Masayuki Yoshikawa: Promoting the effect of chemical constituents from the flowers of Poacynum hendersonii on adipogenesis in 3T3-L1 cells.
Osamu Muraoka、Takao Hayakawa、Masayuki Yoshikawa:促进 Poacynum hendersonii 花化学成分对 3T3-L1 细胞脂肪生成的影响。
DOI: 10.1007/s11418-011-0549-3
发表时间: 2012
期刊: J. Nat. Med.
影响因子: --
作者: [Toshio Morikawa, Katsuya Imura, Sohachiro Miyake, Kiyofumi Ninomiya, Hisashi Matsuda, Chihiro Yamashita]
通讯作者: Chihiro Yamashita
薬用食品から抗糖尿病作用成分の開拓に挑む.
试图从药用食品中发现抗糖尿病成分。
DOI: --
发表时间: 2011
期刊: Yakugaku Zasshi
影响因子: 0.3
作者: [Ochi A, Abe S, Morita EH, 中村誠宏,松田久司,吉川雅之]
通讯作者: 中村誠宏,松田久司,吉川雅之
共 6 条
    Search and development of antidiabetic agents based on anti-AGEs activity
    • 批准号:
      16K08312
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2016
    • 负责人:
      MATSUDA Hisashi
    • 依托单位:
    SEARCH FOR BIOFUNCTIONAL SAPONINS AND THEIR MECHANISMS OF ACTION
    • 批准号:
      18510194
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.63万
    • 财政年份:
      2006
    • 负责人:
      MATSUDA Hisashi
    • 依托单位:
    SEARCH FOR ANTI-METASTATIC AND DIFFERENTIATION-INDUCING ACTIVE COMPOUNDS FROM MEDICINAL PLANTS AND FOODS
    • 批准号:
      16510168
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2004
    • 负责人:
      MATSUDA Hisashi
    • 依托单位:
    Research for biologically active saponins from Japanese and Chinese herbal medicine on the basis of their traditional use.
    • 批准号:
      09672177
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1997
    • 负责人:
      MATSUDA Hisashi
    • 依托单位:
    国内基金
    海外基金
    稳定期COPD中医证型的脂代谢紊乱特征及PPARγ/CPT1A调控机制及临床研究
    • 批准号:
      JCZRLH202601649
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于“郁痰”理论探讨海藻消瘤胶囊调控ERα-PPARγ轴抑制PTC细胞代谢失衡的作用机制
    IPA靶向FABP4/PPARγ信号通路改善肥胖相关性肾小球疾病
    • 批准号:
      2026JJ81107
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      贺超
    • 依托单位:
    M2巨噬细胞外泌体通过MEG3/PPARγ/Nrf2轴介导铁死亡抑制子痫前期进展的作用及机制研究
    • 批准号:
      2026JJ50641
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      喻玲
    • 依托单位: